Objective: Tumor necrosis factor-a (TNFa) plays an important role in the pathogenesis of insulin resistance and type 2 diabetes. Plasma levels of the soluble (s) fractions of TNFa receptors, especially sTNFR2, are good indicators of TNFa system activation in obesity. The aim of the present study was to assess the effect of exercise training on the TNFa system and to evaluate the relationship with changes in insulin sensitivity. Design and methods: Sixteen obese women (body mass index (BMI).27.8 kg/m 2 ), 8 with normal (NGT) and 8 with impaired glucose tolerance (IGT), participated in an exercise training program which lasted for 12 weeks and included exercise performed on a bicycle ergometer at an individual intensity of 70% maximal heart rate, for 30 min, 5 days a week. Anthropometrical measurements and blood biochemical analyses were performed, and plasma TNFa, sTNFR1 and sTNFR2 levels were assessed. Insulin sensitivity was evaluated using the hyperinsulinemic euglycemic clamp technique (insulin infusion: 50 mU Â kg 21 Â h 21 ). Results: At baseline, despite similar anthropometrical parameters, IGT subjects were markedly more insulin resistant and had higher TNFa and sTNFR2 concentrations. Exercise training increased insulin sensitivity and decreased TNFa and sTNFR2 levels, while sTNFR1 remained unchanged. The decrease in sTNFR2 was signi®cantly related to the increase in insulin sensitivity; that relationship remained signi®cant after adjustment for the concurrent changes in BMI, waist circumference, percentage of body fat, plasma glucose, insulin and free fatty acids. Conclusions: Regular physical exercise decreases TNFa system activity and that decrease may be responsible for the concurrent increase in insulin sensitivity.
Introduction
Tumor necrosis factor-a (TNFa) is a cytokine which plays a role in the regulation of tissue glucose and lipid metabolism (1) . It is expressed in human adipose tissue (2, 3) and muscle (4) and is present in higher levels in obese and type 2 diabetic subjects (2±4). It acts probably via autocrine±paracrine mechanisms limiting the amount of body fat (function of`adipostat'), and inducing insulin resistance. Therefore, TNFa may be an important link between obesity and type 2 diabetes mellitus (1) . There are two TNFa cell surface receptors described in humans ± TNFR1 (p60), responsible for differentiation and apoptosis, and TNFR2 (p80), which mediates metabolic actions of TNFa (5) . Both receptors are present in all types of human cells and also in plasma in soluble forms (sTNFR1 and sTNFR2) originated from the cell-surface receptors (6) . Soluble TNFRs may serve as a reservoir of TNFa by stabilizing its bioactivity (7) . It was found that the activation of TNFa leads to overexpression of TNFR2 in adipose tissue and to increased levels of its soluble form in human obesity (6) . sTNFR2 levels correlate with body mass index (BMI), fasting insulin (6) and with insulin resistance (8) , while there is no such correlation for sTNFR1. These data suggest that TNFR2 plays a role in human obesity by modulating the actions of TNFa and inducing insulin resistance (6, 8) . Plasma TNFa values are usually low and do not give precise information about its action in obesity, while sTNFR2 is a much more stable protein. Therefore, it is proposed that sTNFR2 might serve as the best predictor of TNFa system activation and as a diagnostic marker for obese individuals with TNF-related insulin resistance (6) .
A sedentary lifestyle contributes to the increased risk of developing type 2 diabetes (9) . It is generally accepted that prolonged physical exercise increases insulin sensitivity and might be useful in the prevention of type 2 diabetes (9±11). Great interest is focused on metabolic actions of physical exercise in obesity and insulin resistance. However, there is only limited information about the impact of physical exercise on the TNFa system and whether this impact is related to a degree of glucose tolerance. It is also unclear whether the changes in the TNFa system might be responsible for the improvement of insulin sensitivity after exercise training.
In the present study, we examine the in¯uence of physical exercise on the TNFa system in obese women with normal or impaired glucose tolerance. We also evaluate the effect of the TNFa system on concurrent changes in insulin sensitivity during an exercise training program.
Subjects and methods

Study population
Sixteen sedentary obese women were recruited for this study. All the subjects were pre-or perimenopausal and were not on hormone replacement therapy. All the measurements were taken during the luteal phase because sTNFRs may show variation during the menstrual cycle (12) . Subjects underwent an oral glucose tolerance test (OGTT) and on that basis were divided into two groups: one with normal glucose tolerance (NGT, n 8) and the other with impaired glucose tolerance (IGT, n 8), according to the World Health Organization criteria. The inclusion criteria were: age between 30 and 50 years, BMI.27.8 kg/m 2 , stable weight and stable hypocaloric diet (according to questionnaire) during the last 4 months, and a sedentary lifestyle. Subjects were excluded from the study if they had diagnosed diabetes, hypertension resistant to pharmacological treatment, ischemic heart disease, peripheral vascular disease, musculoskeletal system disease, infections, other serious medical problems and if they were smoking cigarettes or taking medications known to affect carbohydrate or lipid metabolism. Before the beginning of the program, subjects were examined by a physician and a 12-lead electrocardiogram exercise test was performed. Additionally, 8 healthy, lean (BMI,25 kg/m 2 ), age-matched women with normal glucose tolerance were examined at baseline and served as a control group. The study was approved by the Ethics Committee of the Medical Academy, Biaøystok, and all the subjects gave written informed consent before participating in the study.
Training protocol
The exercise training program lasted 12 weeks and included exercise performed at the hospital on a bicycle ergometer at an individual intensity of 70% maximal heart rate. Subjects exercised for 30 min, 5 days a week. Thus an approximate total energy expenditure of 1100 kcal/week was reached. All the training sessions were supervised by a physician, and heart rate and blood pressure were monitored during exercise. A minimum 90% compliance to the training program was the criterion for inclusion in the data analysis, that criterion was ful®lled by all 16 subjects. Additionally, subjects were encouraged to increase their individual leisure time activity, for instance by walking or swimming. All the additional activities were recorded every 2 weeks in a specially prepared questionnaire. Individual 3-day diet records were also obtained every 2 weeks from all the subjects.
Measurements
All the measurements were obtained at baseline and after completing a 12-week exercise training protocol. Laboratory analyses were performed at 0800 h after a 12-h overnight fast. Analyses were taken at least 48 h after the last bout of exercise. In the control group measurements were taken only at baseline.
Anthropometry
The BMI was calculated as body weightÂheight 22 and expressed in kg/m 2 . The waist circumference was measured at the smallest circumference between the rib cage and the iliac crest, with the subject in the standing position. Percentage body fat was estimated by bioelectric impedance analysis using the Tanita TBF-511 Body Fat Analyzer (Tanita Corp., Tokyo, Japan). On that basis fat mass (FM) and fat-free mass (FFM) were calculated.
Insulin sensitivity
Insulin sensitivity was evaluated by the euglycemic hyperinsulinemic clamp technique as described previously (13) . On the morning of the study two venous catheters were inserted into antecubital veins: the ®rst one for the infusion of insulin and glucose and the second one in the contralateral hand for blood sampling ± that hand was heated to approximately 60 8C. Insulin (Actrapid HM, Novo Nordisk, Copenhagen, Denmark) was given as a primed-continuous intravenous infusion for 2 h at 50 mU Â kg 21 Â h 21 Y resulting in constant hyperinsulinemia of approximately 550 pmol/l. Arterialized blood glucose was obtained every 5 min and 40% dextrose (2.22 mol/l) infusion was adjusted manually (as modi®ed by Ponchner et al.) (14) to maintain plasma glucose levels at 5.0 mmol/l. The glucose infusion rate approached stable values during the ®nal 40 min of the study and the rate of whole-body glucose uptake (M value) was calculated as the mean glucose infusion rate from 80 to 120 min, corrected for glucose space and normalized per kilogram of fat-free mass (M ffm ). Plasma insulin and free fatty acids (FFA) were also measured during the clamp.
Other blood analyses
Fasting blood samples were also taken from the antecubital vein before the beginning of the clamp for the determination of glycated hemoglobin (HbA1c), plasma lipids, TNFa, sTNFR1 and sTNFR2. For the determination of plasma TNF system samples were frozen at 270 8C.
Analytical procedures
Plasma glucose was measured enzymatically using a commercially available kit (Cormay Glucose, Warsaw, Poland). Plasma insulin were measured in duplicate with the Medgenix EASIA test (BioSource Europe, Nivelles, Belgium). The minimum detectable concentration was 1.05 pg/l and the intra-assay and interassay coef®cients of variation were below 5.5 and 10% respectively. In this method human and animal proinsulins present no cross-reaction. HbA1c was measured by the high-performance liquid chromatography method (Bio-Rad, Munchen, Germany). Plasma cholesterol and triglycerides (TG) were assessed by enzymatic methods (Cormay). Plasma FFA were measured by a colorimetric method (15) .
Plasma TNFa concentrations were measured by the immunoassay kit from BioSource International (Camarillo, CA, USA) with a minimum detectable dose of 1.7 pg/ml and with intra-assay and interassay coef®cients of variation below 5.2 and 8.5% respectively. Plasma sTNFR1 and sTNFR2 were determined with the EASIA kits (BioSource Europe). The minimum detectable concentration was estimated to be 0.05 ng/ml for sTNFR1 and 0.1 ng/ml for sTNFR2. The intra-assay and interassay coef®cients of variation for both receptors were below 6.5 and 9% respectively. sTNFR1 EASIA does not cross react with sTNFR2, and TNFa does not interfere with the assay.
Statistical analysis
All the data are presented as means^S.D. The statistics were performed using the STATISTICA 5.0 program (StatSoft, Krakow, Poland). Comparison between control, NGT and IGT groups was carried out using the Mann-Whitney U test. The statistical signi®cance between variables before and after the training program was analyzed by the Wilcoxon rank sum test. Simple, multiple and stepwise regression analyses were performed to evaluate the relationships between variables. The statistical signi®cance was accepted at a P value of less than 0.05.
Results
The anthropometrical and biochemical characteristics of the studied groups are presented in Tables 1 and 2 .
There was no signi®cant difference in anthropometrical measurements between the NGT and IGT groups. As expected, IGT subjects demonstrated markedly higher fasting plasma glucose, insulin, FFA, and HbA1c when compared with the NGT and control group (P , 0X05 in all cases). Also, IGT subjects were signi®cantly more insulin resistant than NGT subjects and controls (P , 0X005 in both cases). Obese NGT women had markedly higher plasma insulin and HbA1c and lower M ffm in comparison with the control group (all P , 0X05), while the differences in plasma glucose www.eje.org and FFA were approaching the level of signi®cance (glucose: P 0X051; FFA: P 0X065). No signi®cant differences were observed in plasma glucose, insulin and FFA during steady-state clamp conditions between the studied groups ( Fig. 1) . Plasma levels of TNFa and sTNFR2 were signi®cantly higher in both groups of the obese subjects compared with control (IGT vs control: both P , 0X001; NGT vs control: both P , 0X05) and in the IGT compared with the NGT group (both P , 0X005). No differences in plasma sTNFR1 levels were observed between the studied groups ( Table 2) .
Basal sTNFR2 levels correlated positively with BMI, waist circumference, HbA1c, plasma insulin and FFA and negatively with M ffm (Fig. 2) . These correlations remained signi®cant when the lean women were excluded from the analysis (Table 3 ). There were no signi®cant correlations between sTNFR1 and the above parameters. TNFa correlated with sTNFR2 r 0X76; P 0X0005X The correlations between TNFa and the other variables mentioned above, although signi®cant in most cases, were weaker than those for sTNFR2. Therefore, in studying relationships between variables we chose sTNFR2 as the best predictor of TNFa system activity.
Exercise training resulted in a signi®cant decrease in BMI, waist circumference, percentage body fat, HbA1c and FFA in both groups of the obese subjects (all P , 0X05) ( Table 4) . A marked increase in M ffm was also observed (P , 0X02 in both groups). The observed decrease in most of the parameters was similar in NGT and IGT groups, while alterations in plasma FFA and the M ffm value were markedly more pronounced in the IGT group (DFFA and DM ffm : IGT vs NGT, P , 0X02).
We demonstrated a signi®cant impact of exercise training on the TNFa system: after completing the study plasma TNFa and sTNFR2 decreased signi®-cantly in both groups (all P , 0X02), while sTNFR1 levels remained unchanged ( Table 5 ). The observed decrease in sTNFR2 was markedly greater in the IGT group P , 0X05Y while for the changes in TNFa there was no such difference.
The fall in sTNFR2 was the greatest in the subjects with the highest baseline sTNFR2 r 0X52; P , 0X05 and the lowest M ffm r 20X62; P , 0X01X During training, sTNFR2 levels changed concurrently with the decrease in waist circumference r 0X51; P , 0X05Y FFA r 0X59; P , 0X02 and with the increase in insulin sensitivity r 20X70; P , 0X005 (Fig. 3) .
During multiple regression analysis with DM ffm as the dependent variable, we found that DsTNFR2 was determining the M ffm changes independently of changes in BMI, waist circumference, percentage body fat, and plasma glucose, insulin and FFA (beta value=20.53; P , 0X05). In a stepwise regression analysis only the changes in waist circumference and sTNFR2 were independent factors in¯uencing the changes in insulin sensitivity R 2 0X77; P , 0X001 with changes in BMI, percentage body fat, plasma glucose, insulin and FFA not entering the regression model. According to the questionnaire, in almost all the patients additional physical activity consisted of 30 min walking and/or biking daily. Diet records collected during the study did not differ signi®cantly from the questionnaire which was ®lled in at the beginning of the study. The approximate daily intake was 1200±1400 kcal.
Discussion
In the present study we demonstrated a signi®cant decrease in TNFa and sTNFR2 after exercise training, observed in both NGT and IGT groups. It remains unclear what is the source of the increased circulating TNFa in obese individuals; however, adipose tissue is the probable candidate because of the overexpression of the TNFa gene. TNFa levels are also dependent on type of obesity (16) . Previous studies reported a marked decrease of TNFa expression in adipose tissue (2, 3) and a decrease in circulating TNFa (17, 18) after weight loss. We also observed a slight decrease in body weight, waist circumference and fat mass, which is attributed mainly to the increase in physical activity, as the hypocaloric diet was unchanged in comparison with the pre-treatment period. However, body weight decreased by 2.19% and fat mass by 7.90%, and it was accompanied by a 19.57% loss of TNFa and a 19.85% loss of sTNFR2. Therefore, we suggest that increased physical activity has an independent effect regulating the TNF system, which cannot be attributed only to changes in body fat. It was reported that TNFa is also overexpressed in skeletal muscle of insulin resistant and diabetic subjects (4). Fernandez-Real et al. reported that sTNFR2 correlated with fat-free mass and suggested that circulating sTNFR2 is produced not only by the adipocytes but also by the muscle (8) . We were unable to detect such a relationship at baseline, but this is probably due to a rather narrow range of FFM values in our subjects and to the selection of the study groups (weight-matched insulin-resistant IGT subjects had slightly higher percentage of body fat and slightly lower FFM). However, in the present study FFM did not change signi®cantly after training. Although our study does not answer that question, it is possible that muscle contraction may directly regulate local TNFa expression and muscle activity may be more important than muscle mass. Increased sTNFR2 concentrations were found in patients with myotonic dystrophy (19) . The authors speculated that disorders of the muscle cell membrane could lead both to insulin resistance and to sTNFR2 leakage. It is also possible that muscle inactivity may modulate TNFa system action in that group of patients.
In a very recently published paper the in¯uence of moderate physical exercise on plasma TNFa was also examined (20) and the decrease in TNFa and both sTNFRs in healthy women was observed. Changes in sTNFRs were not related to changes in anthropometrical measurements (20) . We did not ®nd any effect of exercise training on sTNFR1. The discrepancy between the two studies cannot be explained by the inclusion of the IGT group in our study, as the IGT group had similar anthropometrical parameters and sTNFR1 levels as the NGT group. However, in the present study baseline sTNFR1 levels in obese subjects were not increased compared with controls. This is consistent with the previously reported results (6, 8) .
We suppose that the two sTNFRs are regulated in different ways because of their different functions (5) . In contrast to the above data, increased sTNFR1 levels in obesity were also observed (20, 21) and this discrepancy has not been explained so far. The difference may come from the selection of study subjects ± men show higher levels of sTNFRs than women (8) , and in women there could also be a variation due to a menstrual cycle (12) . In the cited paper, the decrease in TNFa was related to the decrease in FFM (20) ; however we think that this may not be applicable to all situations as unchanged and increased values of FFM after endurance training were also reported (22) .
Another important ®nding of our study is that decreases in TNFa and sTNFR2 are related to the increase in insulin sensitivity after exercise training. The mechanisms by which physical activity enhances insulin action are not fully understood. It is well-known that skeletal muscle is the major site of insulin action and accounts for about 90% of insulin-stimulated glucose uptake during an insulin clamp (23) . Increased FFA supply from visceral fat to muscle may suppress glucose utilization through a glucose±fatty acids cycle (24) . Therefore, one of the proposed mechanisms explaining the relationship between changes in sTNFR2 and insulin sensitivity may be decreased lipolysis and FFA delivery, as alterations in sTNFR2 paralleled those of waist circumference and FFA levels. However, the relationship between changes in sTNFR2 and insulin sensitivity remained signi®cant after adjustment for the concurrent changes in waist circumference, FFA and other measurements of adiposity. Changes of waist circumference and sTNFR2 were both independent correlates of the increase in M ffm suggesting different mechanisms of action. Saghizadeh et al. found a signi®cant inverse relationship between muscle TNF and maximal glucose disposal rate (4). They speculated that disordered TNF regulation in muscle may be an important part of insulin resistance. Although TNF acts locally in muscle, circulating sTNFR2 may re¯ect local action of the cytokine (6) . We present data, the ®rst to our knowledge, that changes in the TNF system are related to the improvement in insulin sensitivity during prolonged physical activity. Although our results do not reveal any cause±effect relationship, we can hypothesize that muscle contraction may decrease local TNFa and sTNFR2 expression and this may lead to the increased insulin sensitivity. There are also other changes resulting in enhanced insulin action following training, such as increased amount of the glucose transporter GLUT4 (25±27), increased capillarization of the muscle tissue (28) and enhanced insulin signal transduction, for example at the level of phosphatidylinositol 3-kinase activity (29) . Therefore, a decrease in TNFa expression is only one among many other proposed mechanisms.
It is generally accepted that individuals who are at highest risk of developing type 2 diabetes, i.e. with the greatest visceral obesity, impaired glucose tolerance and insulin resistance, bene®t most from performing regular physical activity (9) . In the present study, increase in insulin sensitivity was greater in IGT subjects despite similar changes in anthropometrical measurements of obesity, while the decrease in sTNFR2 was markedly larger in this group. Our data show that regulation of the TNFa system by physical activity is dependent on the glucose tolerance status and baseline sTNFR2 levels, and this may contribute to differences in metabolic response to exercise training in different groups of subjects. The present study does not explain the reason for such differences. 
